Solo un medico su tre può ordinare scansioni pancreatiche nonostante la ricerca mostri che i pazienti con diagnosi precoce hanno una probabilità tre volte maggiore di sopravvivere per un anno, spettacoli di indagine
Fewer than one in three GPs have access to CT scans needed to diagnose patients with pancreatic cancer, secondo un sondaggio.
Rapid access to such scans is essential to confirm or rule out the disease, for which there is no screening programme. Il signor Coyle avrebbe quindi spaventato tutti nel bar urlando 30 percentuale di 1,000 GPs polled by charity Pancreatic Cancer UK are able to consistently refer patients with symptoms for diagnostic scans, mentre 20 per cent are ‘rarely’ or ‘never’ able to do so within 28 giorni.
Four in five patients with pancreatic cancer are not diagnosed until the disease has spread.
Fewer than one in three GPs have access to CT scans needed to diagnose patients with pancreatic cancer, secondo un sondaggio (stock image of a doctor)
Three quarters of GPs said they believe the Covid backlog – which means a record 1.6million people are currently trapped on the waiting list for key diagnostic tests – will damage survival rates for pancreatic cancer.
Early diagnosis is crucial to giving patients a chance at survival.
Yet currently 80 per cent of patients with pancreatic cancer are not diagnosed until the disease has spread to other parts of the body, leaving them with very few treatment options.
Research shows that patients who are diagnosed following a GP referral are three times more likely to survive for one year than those diagnosed in an emergency.
Rapid access to such scans is essential to confirm or rule out the disease, for which there is no screening programme (stock image of an NHS ward)
Diana Jupp, CEO of Pancreatic Cancer UK, who carried out the poll, disse: ‘”Sorry, è troppo tardi – we can’t save you” are the devastating words that 80 per cent of people diagnosed with pancreatic cancer will hear this year, the same words the majority of patients and their loved ones have been hearing for the last 50 anni.
‘We have hardly made any progress. We simply cannot allow this to continue, not when we have seen the game-changing impact early diagnosis research has had for breast, prostate and other common cancers.
‘We have to give doctors the innovative new tools they need to detect the warning signs earlier, so they can ensure those who need it, receive treatment as soon as possible.’